Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib Meeting Abstract
| Authors: | Mauro, M. J.; Lang, F.; Kim, D. W.; Cortes, J. E.; Hughes, T. P.; Hochhaus, A.; Minami, H.; Boquimpani, C.; Minami, Y.; DeAngelo, D. J.; Breccia, M.; Talpaz, M.; Goh, Y. T.; Ottmann, O.; Sondhi, M.; Hois, S.; Bédoucha, V.; Schmitz, S. F. H.; Rea, D. |
| Abstract Title: | Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 398s |
| Language: | English |
| ACCESSION: | WOS:000442916007712 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS7081 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS7081 -- Source: Wos |
